TIANSHENG PHARMACEUTICAL GROUP CO., LTD.

Tiansheng Pharmaceutical Group Co., Ltd.

002872

CNE100002QC3

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
4.33 ^CNY	-0.92%		+2.36%	-15.59%

2023	Tiansheng Pharmaceutical Group Co., Ltd. Announces Executive Appointments	CI
2023	Tiansheng Pharmaceutical’s Paracetamol Tablet Passes Consistency Test	MT

Tiansheng Pharmaceutical Group Co., Ltd. Announces Executive Appointments

November 27, 2023 at 02:33 pm EST

Tiansheng Pharmaceutical Group Co., Ltd. at the Extraordinary General Meeting held on 24 November 2023 approved election of non-independent directors, cumulative voting system applicable: Wang Xin; Election of independent directors, cumulative voting system applicable: Yi Runzhong; Election of non-employee supervisors, cumulative voting system applicable: Yu Jianwei.

Latest news about Tiansheng Pharmaceutical Group Co., Ltd.

Tiansheng Pharmaceutical Group Co., Ltd. Announces Executive Appointments	Nov. 27	CI
Tiansheng Pharmaceutical’s Paracetamol Tablet Passes Consistency Test	Nov. 17	MT
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Tiansheng Pharmaceutical's Technology Center Named National Enterprise Technology Center	23-02-24	MT
Tiansheng Pharmaceutical Unit Gets Regulatory Approval for Injection	22-11-18	MT
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-24	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-26	CI
Chongqing Pharmaceutical CO., LTD. completed the acquisition of 51% stake in Chongqing Changsheng Medicine Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd..	21-04-28	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-04-26	CI
Tiansheng Pharmaceutical Group Co., Ltd. Approves Election of Directors	20-12-14	CI
An unknown buyer acquired 11% stake in Hubei Xianming Medical Apparatus and Instruments Co., Ltd. from Hubei Xianming Medical Apparatus and Instruments Co., Ltd. for CNY 5.1 million.	20-11-04	CI
An unknown buyer acquired Chongqing Xinmei Pharmaceutical Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd. for CNY 0.	20-11-04	CI
Chongqing Pharmaceutical CO., LTD. signed an equity transfer intention agreement to acquire 51% stake in Chongqing Changsheng Medicine Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd. for CNY 59.6 million.	20-02-12	CI
Tiansheng Pharmaceutical Group Co., Ltd. cancelled the acquisition of Chongqing Dachuang Electrical Equipment Co., Ltd. from Chongqing Changlong Industrial Co., Ltd.	18-12-11	CI
Tiansheng Pharmaceutical Group Co., Ltd. cancelled the acquisition of Chongqing Junyao Pharmaceutical Packing Products Co., Ltd. from Chen Yi and Feng Yi.	18-09-17	CI
Luzhou Tiansheng Pharmaceutical Co., Ltd. announced that it expects to receive CNY 150 million in funding from Tiansheng Pharmaceutical Group Co., Ltd.	18-02-12	CI
Tiansheng Pharmaceutical Group Co., Ltd. agreed to acquire Chongqing Dachuang Electrical Equipment Co., Ltd. from Chongqing Changlong Industrial Co., Ltd. for CNY 31 million.	17-12-12	CI
Tiansheng Pharmaceutical Group Co., Ltd. Forms Medical Appliances Joint Venture in Chongqing City, China	17-11-19	CI
Tiansheng Pharmaceutical Group Co., Ltd. entered into an agreement to acquire Chongqing Junyao Pharmaceutical Packing Products Co., Ltd. from Chen Yi and Feng Yi for CNY 0.23 million.	17-09-19	CI
Tiansheng Pharmaceutical Group Co., Ltd. completed the acquisition of 51% stake in Hubei Xianming Medical Machinery Co., Ltd. from Li Qiqing, Li Wenhui, and Li Wenfeng.	17-09-11	CI
Tiansheng Pharmaceutical Group Co., Ltd. signed a share transfer agreement to acquire 51% stake in Hubei Xianming Medical Machinery Co., Ltd. from Li Qiqing, Li Wenhui, and Li Wenfeng for CNY 5.1 million.	17-08-10	CI

Chart Tiansheng Pharmaceutical Group Co., Ltd.

Duration

Period

Chart Tiansheng Pharmaceutical Group Co., Ltd.

More charts

Company Profile

Tiansheng Pharmaceutical Group Co LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company's main products include pediatric lung cough particles, erythromycin enteric-coated capsules, silver ginseng Tongluo capsules, Salvia granules, Shugan Yi spleen granules, compound Ganoderma lucidum granules, Xiangdan injection, Injection, Qi and Diabetes tablets, liver capsule, Ling Jing capsule, lungs of nuclear paste, Shen Qi Yi lung pill, among others. The Company mainly distributes its products within domestic market.

Sector

Pharmaceuticals

Calendar

2024-05-16 - Annual General Meeting

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TIANSHENG PHARMACEUTICAL GROUP CO., LTD.	-15.59%	190M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals